Abstract
Background: Lipodystrophy is one of the most frequent complications in people with diabetes following subcutaneous insulin therapy, and poor management can lead to several problems, such as impaired glycemic control and adherence to therapy, anxiety, and depression. Poor injection technique represents the main risk factor for lipodystrophies. In order to enhance the patient’s insulin injection technique to heal lipodystrophy, improve psychological indices, and promote involvement in their health and care, the efficacy of emerging person-centered care called the IARA model was tested. Methods: A total of 49 patients were randomly allocated to the IARA group (Experimental; n = 25) or standard education (Control; n = 24). The following questionnaires were used in a mixed-method design: (i) State Anxiety Scale; (ii) Beck Depression Inventory; (iii) Italian Summary of Diabetes Self-Care Activities. An ad hoc open-ended questionnaire was structured for the qualitative analysis. Finally, photos were taken in order to verify if injection sites were changed until the follow-up at 12 months. The number of patients who participated until the completion of the study was 17 in the IARA and 11 in the Control group. Results: State anxiety was significantly reduced in people who followed IARA to follow-up at 3 and 6 months (p < 0.05). The IARA group also demonstrated better compliance in blood glucose monitoring and foot-care compared to Control at follow-up at 12 months. The management of insulin injections dramatically improved in participants who received IARA intervention. Conclusions: IARA could be considered an effective strategy to improve well-being and compliance in people affected with diabetes mellitus and lipodystrophy complications.
Reference66 articles.
1. (2022, October 10). Diabetes. Available online: https://www.who.int/health-topics/diabetes#tab=tab_1.
2. (2022, October 10). Diabete—Aspetti Epidemiologici. Available online: https://www.epicentro.iss.it/diabete/epidemiologia-italia.
3. Global trends in diabetes complications: A review of current evidence;Diabetologia,2019
4. (2022, September 03). World Health Organization Global Report on Diabetes. Available online: https://www.who.int/publications/i/item/9789241565257.
5. American Diabetes Association (2021). ADA Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes—2021. Diabetes Care, 44, S111–S124.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献